Goldman Sachs flags downturn risk for Europe chemicals sector
BUZZ-Goldman Sachs flags downturn risk for Europe chemicals sector ** Goldman Sachs sees European chemicals facing another downturn after initially remaining pro-cyclical in the early months of the Middle East conflict
** It cites faster-than-expected demand destruction, as well as Chinese export pressure weighting on the anticipated market share gains
** Europe's chemicals index .SX4P is up about 11% since its December 2025 trough, outperforming the STOXX 600 .SXXP by roughly 3 percentage points, but earnings expectations are increasingly driven by pricing rather than volumes, GS says
** "With a new inflation cycle underway, preference is shifting toward companies with defensive pricing power and secular growth exposure," it adds
** Shares of Arkema AKE.PA and DSM-Firmenich DSFIR.AS are down 2.5%, while Syensqo SYENS.BR drops 3.5%
COMPANY | NEW RATING | OLD RATING | NEW PT | OLD PT |
DSM-Firmenich | Sell | Neutral | EUR 65 | EUR 75 |
Syensqo | Sell | Buy | EUR 59 | EUR 70 |
Evonik | Neutral | Buy | ||
Clariant | Neutral | Sell | CHF 8.50 | CHF 7.50 |
Givaudan | Buy | Sell | CHF 3,500 | CHF 2,900 |
Symrise | Neutral | Buy | ||
Arkema | Neutral | Buy |
(Reporting by Anastasiia Kozlova and Ferdinand Eibach)
((Anastasiia.Kozlova@thomsonreuters.com))
Recent news on Evonik Industries AG
See all newsBrief: Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site
German chemical industry confidence improves sharply in June, Ifo says (updated)
German chemical sector gets temporary lift from Middle East disruptions, Ifo says
Evonik raise full-year outlook as Middle East disruption hits Asian rivals (updated)
Evonik raises full-year profitability outlook after Q2 beat